PROTEOCYTE AI
Proteocyte AI is focused in the computational pathology sector, combing artificial intelligence and protein biomarkers to determine a patient’s 5-year risk of developing cancer. This is technology that predicts who is at risk to develop cancer before they actually have cancer.
PROTEOCYTE AI
Industry:
Artificial Intelligence Collaboration Health Care Health Diagnostics Hospitality Machine Learning
Founded:
2011-08-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.proteocyte.com
Total Employee:
11+
Status:
Active
Contact:
416-994-4051
Total Funding:
554.1 K USD
Technology used in webpage:
SPF Google Apps For Business Google Maps Google Google Maps API Google Cloud Pound Sterling Japanese Yen Google Maps For Work NetFirms DNS
Current Advisors List
Advisor
Current Employees Featured
Anthony Morlandt CEO @ Proteocyte AI
CEO
Kenneth Pritzker Co-Medical Director @ Proteocyte AI
Co-Medical Director
Investors List
Golden Triangle Angel Network
Golden Triangle Angel Network investment in Seed Round - Proteocyte AI
Freycinet Ventures
Freycinet Ventures investment in Seed Round - Proteocyte AI
Laurier Start-up Fund
Laurier Start-up Fund investment in Seed Round - Proteocyte AI
Ontario Centres of Excellence
Ontario Centres of Excellence investment in Seed Round - Proteocyte AI
Official Site Inspections
http://www.proteocyte.com
- Host name: 172.67.161.55
- IP address: 172.67.161.55
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Proteocyte AI"
Designing Tests That Predict Your Risk of Developing …
Proteocyte’s first product, Straticyte™, is a test that predicts the progression of pre-malignant lesions to invasive oral cancer.Straticyte enables healthcare …See details»
Proteocyte AI - Crunchbase Company Profile & Funding
Proteocyte AI is a molecular diagnostics company developing solutions to predict the risk of developing cancer. Its platform identifies specific protein biomarkers that operate in …See details»
Take Charge of Your Health With STRATICYTE
Proteocyte is committed to enriching its dataset with annotated study cohorts and has several ongoing studies with major Canadian oral pathology centres. ...See details»
Frequently Asked Questions | Proteocyte
Dr. Ranju Ralhan. Dr Ranju Ralhan is the co-inventor of Proteocyte’s biomarker technology. She was formerly Professor in the Department of Pathology & Laboratory Medicine, Co-Director, …See details»
Organization/Accreditation Information - customer.a2la.org
Organization Name: Proteocyte Diagnostics Inc. Web: https://proteocyte.com. Address: MaRS Centre, South Tower 101 College Street, Suite 200, O-219 Toronto, ON M5G 1L7 Canada …See details»
Proteocyte Diagnostics Inc. | Toronto, ON, Canada …
Proteocyte commercializes Straticyte a molecular diagnostic test that accurately detects oral cancer before it happens to save lives and save health care costs. Straticyte predicts the probability of a precancerous lesion becoming cancer in …See details»
Proteocyte - Products, Competitors, Financials, Employees, …
About Proteocyte. Proteocyte is a med-tech company that focuses on cancer risk prediction and diagnostics within the healthcare sector. The company offers a platform that uses protein …See details»
Proteocyte AI - The Org
Proteocyte AI is focused in the computational pathology sector, combing artificial intelligence and protein biomarkers to determine a patient’s 5-year risk of developing cancer. This is …See details»
Proteocyte - VentureRadar
Proteocyte AI is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with …See details»
Proteocyte Diagnostics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Proteocyte Diagnostics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 4 literature.See details»
New Management and Clinical Advisory Board - Proteocyte …
Jan 8, 2021 MaRS Discovery District, Toronto, ON; January 8, 2021 – Proteocyte AI, a personalized medicine and diagnostics company located in MaRS Center, Toronto ON, …See details»
Proteocyte AI - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 27, 2014: Seed Round - …See details»
Proteocyte Receives Support from NRC-IRAP for Straticyteâ„¢
Dec 21, 2015 Proteocyte Diagnostics was the highest ranked life science Company at the National Angel Capital Organization (NACO) Most Promising Canadian Start Up of the Year …See details»
Proteocyte Diagnostics initiates a cost-effectiveness analysis
Aug 28, 2014 Mitacs is a national, private not-for-profit organization that has designed and delivered unique research and training programs in Canada for 15 years. In partnership with …See details»
Proteocyte Diagnostics - Overview, News & Similar companies
Who is Proteocyte Diagnostics. Proteocyte Diagnostics Inc. is a Canadian molecular diagnostics company that has developed a novel diagnostics technology, Straticyte, which offers accurate …See details»
Proteocyte AI Company Overview, Contact Details & Competitors
Proteocyte Diagnostics Inc. hired Mark Smithyes as strategic advisor on Nov 3rd '23. Toronto, ON; November 3, 2023 - Proteocyte AI is pleased to announce that Mark Smithyes has joined …See details»
Today Proteocyte Diagnostics becomes…
Toronto, ON; March 9, 2018 – Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, announced …See details»
Proteocyte AI - Medhealth Outlook
As Proteocyte AI continues to innovate and expand its suite of prognostic solutions, the company remains committed to its mission of transforming cancer prognosis and management. Through …See details»
Select Presentations, Publications and Press Releases | Proteocyte
Dr. Ranju Ralhan. Dr Ranju Ralhan is the co-inventor of Proteocyte’s biomarker technology. She was formerly Professor in the Department of Pathology & Laboratory Medicine, Co-Director, …See details»
Proteocyte AI continues to expand evidence for Straticyte's clinical ...
Toronto, ON; March 5, 2025 –Proteocyte AI—an innovative company that develops and commercializes individualized tests to predict risk of developing cancer, has recently learned …See details»